360 related articles for article (PubMed ID: 25035212)
1. Lymphopenia association with gross tumor volume and lung V5 and its effects on non-small cell lung cancer patient outcomes.
Tang C; Liao Z; Gomez D; Levy L; Zhuang Y; Gebremichael RA; Hong DS; Komaki R; Welsh JW
Int J Radiat Oncol Biol Phys; 2014 Aug; 89(5):1084-1091. PubMed ID: 25035212
[TBL] [Abstract][Full Text] [Related]
2. Impact of Radiation Dose to the Host Immune System on Tumor Control and Survival for Stage III Non-Small Cell Lung Cancer Treated with Definitive Radiation Therapy.
Ladbury CJ; Rusthoven CG; Camidge DR; Kavanagh BD; Nath SK
Int J Radiat Oncol Biol Phys; 2019 Oct; 105(2):346-355. PubMed ID: 31175902
[TBL] [Abstract][Full Text] [Related]
3. Prognostic value of gross tumor volume for definitive radiation therapy in patients with locoregionally recurrent non-small-cell lung cancer after surgical resection.
Lee NK; Moon SH; Kim TH; Han JY; Yun T; Kim HT; Lee HS; Kim MS; Lee JM; Cho KH; Lee JS
Clin Lung Cancer; 2013 Jul; 14(4):399-406. PubMed ID: 23276823
[TBL] [Abstract][Full Text] [Related]
4. Treatment-duration is related to changes in peripheral lymphocyte counts during definitive radiotherapy for unresectable stage III NSCLC.
Zhao Q; Chen G; Ye L; Shi S; Du S; Zeng Z; He J
Radiat Oncol; 2019 May; 14(1):86. PubMed ID: 31133034
[TBL] [Abstract][Full Text] [Related]
5. Results of multifield conformal radiation therapy of nonsmall-cell lung carcinoma using multileaf collimation beams.
Bahri S; Flickinger JC; Kalend AM; Deutsch M; Belani CP; Sciurba FC; Luketich JD; Greenberger JS
Radiat Oncol Investig; 1999; 7(5):297-308. PubMed ID: 10580899
[TBL] [Abstract][Full Text] [Related]
6. Prognostic value of neutrophil-to-lymphocyte ratio change in patients with locally advanced non-small cell lung cancer treated with thoracic radiotherapy.
Yin X; Chen H; Sun Y; Xiao L; Lu H; Guo W; Yang H; Zhou J; Fan K; Liang W
Sci Rep; 2024 May; 14(1):11984. PubMed ID: 38796631
[TBL] [Abstract][Full Text] [Related]
7. DART-bid (Dose-differentiated accelerated radiation therapy, 1.8 Gy twice daily)--a novel approach for non-resected NSCLC: final results of a prospective study, correlating radiation dose to tumor volume.
Wurstbauer K; Deutschmann H; Dagn K; Kopp P; Zehentmayr F; Lamprecht B; Porsch P; Wegleitner B; Studnicka M; Sedlmayer F
Radiat Oncol; 2013 Mar; 8():49. PubMed ID: 23497555
[TBL] [Abstract][Full Text] [Related]
8. Definitive reirradiation for locoregionally recurrent non-small cell lung cancer with proton beam therapy or intensity modulated radiation therapy: predictors of high-grade toxicity and survival outcomes.
McAvoy S; Ciura K; Wei C; Rineer J; Liao Z; Chang JY; Palmer MB; Cox JD; Komaki R; Gomez DR
Int J Radiat Oncol Biol Phys; 2014 Nov; 90(4):819-27. PubMed ID: 25220718
[TBL] [Abstract][Full Text] [Related]
9. Effects of lymphopenia on survival in proton therapy with chemotherapy for non-small cell lung cancer.
Nakamura M; Ishikawa H; Ohnishi K; Mori Y; Baba K; Nakazawa K; Shiozawa T; Sekine I; Maruo K; Okumura T; Sakurai H
J Radiat Res; 2023 Mar; 64(2):438-447. PubMed ID: 36592478
[TBL] [Abstract][Full Text] [Related]
10. Impact of early tumor reduction on outcome differs by histological subtype in stage III non-small-cell lung cancer treated with definitive radiotherapy.
Kanzaki H; Kataoka M; Nishikawa A; Uwatsu K; Nagasaki K; Nishijima N; Ochi T; Mochizuki T
Int J Clin Oncol; 2016 Oct; 21(5):853-861. PubMed ID: 27125214
[TBL] [Abstract][Full Text] [Related]
11. Lymphopenia Is Associated with Gross Target Volumes and Fractions in Hepatocellular Carcinoma Patients Treated with External Beam Radiation Therapy and Also Indicates Worse Overall Survival.
Zhang HG; Yang P; Jiang T; Zhang JY; Jin XJ; Hu Y; Sun J; Du SS; Zeng ZC
Can J Gastroenterol Hepatol; 2019; 2019():9691067. PubMed ID: 31781521
[TBL] [Abstract][Full Text] [Related]
12. Is pulmonary artery a dose-limiting organ at risk in non-small cell lung cancer patients treated with definitive radiotherapy?
Ma JT; Sun L; Sun X; Xiong ZC; Liu Y; Zhang SL; Huang LT; Han CB
Radiat Oncol; 2017 Feb; 12(1):34. PubMed ID: 28143532
[TBL] [Abstract][Full Text] [Related]
13. Is tumor volume reduction during radiotherapy prognostic relevant in patients with stage III non-small cell lung cancer?
Elsayad K; Samhouri L; Scobioala S; Haverkamp U; Eich HT
J Cancer Res Clin Oncol; 2018 Jun; 144(6):1165-1171. PubMed ID: 29623466
[TBL] [Abstract][Full Text] [Related]
14. Late-Course Adaptive Adjustment Based on Metabolic Tumor Volume Changes during Radiotherapy May Reduce Radiation Toxicity in Patients with Non-Small Cell Lung Cancer.
Xiao L; Liu N; Zhang G; Zhang H; Gao S; Fu Z; Wang S; Yu Q; Yu J; Yuan S
PLoS One; 2017; 12(1):e0170901. PubMed ID: 28125698
[TBL] [Abstract][Full Text] [Related]
15. Postoperative radiotherapy increases locoregional control of patients with stage IIIA non-small-cell lung cancer treated with induction chemotherapy followed by surgery.
Taylor NA; Liao ZX; Stevens C; Walsh G; Roth J; Putnam J; Fossella F; Allen P; Cox JD; Komaki R
Int J Radiat Oncol Biol Phys; 2003 Jul; 56(3):616-25. PubMed ID: 12788166
[TBL] [Abstract][Full Text] [Related]
16. Lymphocyte Nadir and Esophageal Cancer Survival Outcomes After Chemoradiation Therapy.
Davuluri R; Jiang W; Fang P; Xu C; Komaki R; Gomez DR; Welsh J; Cox JD; Crane CH; Hsu CC; Lin SH
Int J Radiat Oncol Biol Phys; 2017 Sep; 99(1):128-135. PubMed ID: 28816138
[TBL] [Abstract][Full Text] [Related]
17. Influence of Surveillance PET/CT on Detection of Early Recurrence After Definitive Radiation in Stage III Non-small-cell Lung Cancer.
Reddy JP; Tang C; Shih T; Kim B; Kim C; Nguyen QN; Welsh J; Benveniste M; Zhang J; Liao Z; Gomez DR
Clin Lung Cancer; 2017 Mar; 18(2):141-148. PubMed ID: 27913215
[TBL] [Abstract][Full Text] [Related]
18. Gross tumor volume, critical prognostic factor in patients treated with three-dimensional conformal radiation therapy for non-small-cell lung carcinoma.
Bradley JD; Ieumwananonthachai N; Purdy JA; Wasserman TH; Lockett MA; Graham MV; Perez CA
Int J Radiat Oncol Biol Phys; 2002 Jan; 52(1):49-57. PubMed ID: 11777621
[TBL] [Abstract][Full Text] [Related]
19. Radiotherapy alone for medically inoperable stage I non-small-cell lung cancer: the Duke experience.
Sibley GS; Jamieson TA; Marks LB; Anscher MS; Prosnitz LR
Int J Radiat Oncol Biol Phys; 1998 Jan; 40(1):149-54. PubMed ID: 9422571
[TBL] [Abstract][Full Text] [Related]
20. Prognostic impact of radiation therapy to the primary tumor in patients with non-small cell lung cancer and oligometastasis at diagnosis.
Lopez Guerra JL; Gomez D; Zhuang Y; Hong DS; Heymach JV; Swisher SG; Lin SH; Komaki R; Cox JD; Liao Z
Int J Radiat Oncol Biol Phys; 2012 Sep; 84(1):e61-7. PubMed ID: 22503522
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
